Thanks Denbo, nice to see a fellow holder with similar feelings, issues and logic to me, there'd not be many of us left I suspect. Good luck Sir
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling